Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Memantine as adjunctive therapy for manic episodes in bipolar disorder
IRCT20250430065539N1Phase 3Completed
- Sponsor
- Shiraz University of Medical Sciences
- Start
- Jun 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of memantine in bipolar disorder (BD), sponsored by Shiraz University of Medical Sciences. Started Jun 2025; status: completed.
02
Drugs
memantine
03
Conditions
bipolar disorder (BD)
Beyond the preview
Go deeper on IRCT20250430065539N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20250430065539N1.